Lessons learned from thermosensitive liposomes for improved chemotherapy

Journal of Controlled Release

Volumn 174, Issue 1, 2014, Pages 219-

  Park, Kinam ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; LIPOSOME; THERMOSENSITIVE LIPOSOME; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; BIOACCUMULATION; CANCER CHEMOTHERAPY; CANCER INHIBITION; DRUG EFFICACY; DRUG RELEASE; EDITORIAL; HEAT SENSITIVITY; HUMAN; HYPERTHERMIC THERAPY; LIPOSOMAL DELIVERY; NONHUMAN; PRIORITY JOURNAL; SLOW RELEASE FORMULATION; THERAPY EFFECT; TUMOR VASCULARIZATION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; HUMANS; HYPERTHERMIA, INDUCED; MELANOMA; POLYETHYLENE GLYCOLS;

EID: 84892960121     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.01.001     Document Type: Editorial

References (4)

1. R.D. Issels, L.H. Lindner, J. Verweij, P.Wust, P. Reichardt, B.C. Schem, S. Abdel-Rahman, S. Daugaard, C. Salat, C.M.Wendtner, Z. Vujaskovic, R.Wessalowski, K.W. Jauch, H.R. Dürr, F. Ploner, A. Baur-Melnyk, U. Mansmann, W. Hiddemann, J.Y. Blay, P. Hohenberger, Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study, Lancet Oncol. 1 (2010) 561-570.
2. L. Li, T.L. ten Hagen, M. Bolkestein, A. Gasselhuber, J. Yatvin, G.C. van Rhoon, A.M. Eggermont, D. Haemmerich, G.A. Koning, Improved intratumoral nanoparticle extravasation and penetration bymild hyperthermia, J. Control. Release 167 (2013) 130-137.
3. D. Needham, Reverse engineering the low temperature sensitive liposome (LTSL) for treating cancer, in Biomaterials for Cancer Therapeutics, K. Park (Ed.),Woodhead Publishing Ltd, Oxford, UK, 2013, (Ch. 12.).
4. L. Li, T.L. Ten Hagen, A. Haeri, T. Soullié, C. Scholten, A.L. Seynhaeve, A.M. Eggermont, G.A. Koning, A novel two-step mild hyperthermia for advanced liposomal chemotherapy, J. Control. Release 174 (2014) 202-208.